Blueberries Medical Overview
Latest ROE for Blueberries Medical: -3706.26% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-3706.26%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Blueberries Medical (BBM.CN) currently reports a ROE of -3706.26%. That is below the sector sector average of 11.75%. Use the charts on this page to explore Blueberries Medical's ROE history and peer comparisons.
Blueberries Medical's ROE of -3706.26% is lower than the its sector sector average of 11.75%. That is roughly 31631.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Blueberries Medical's current -3706.26% should be judged against industry norms (sector average: 11.75%) and against BBM.CN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -3706.26%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.75%. From there, open related valuation or income-statement pages for Blueberries Medical, and consider following BBM.CN for alerts when major investors trade the stock.
